T1	Participants 32 56	healthy adults in China.
T2	Participants 131 147	adults in China.
T3	Participants 197 211	healthy adults
T4	Participants 250 265	healthy adults.
T5	Participants 285 430	5143 healthy adults received 10 Î¼g hepatitis B vaccine at 0, 1 and 3 months(group A), 0, 1 and 6 months(group B), or 0, 1 and 12 months(group C)
T6	Participants 678 756	study, 2438 healthy adults finished the full vaccination program and follow-up
